Ahnak, a 700 kDa protein, is expressed in a variety of cells and has been implicated in different cell-type-specific functions. In the human heart, we observed an endogenous carboxyl-terminal 72 kDa ahnak fragment that copurified with myofibrillar proteins. Immunocytochemistry combined with confocal microscopy localized this fragment to the intercalated discs and close to the Z-line of cardiomyocytes. No endogenous myofibrillar ahnak fragment was observed in the skeletal muscle. We elucidated the role of the recombinant carboxyl-terminal ahnak fragment (ahnak-C2) in actin filament organization and in the function of muscle fibers. Addition of ahnak-C2 to actin filaments induced filament bundling into paracrystalline-like structures as revealed by electron microscopy. Incubation of demembranated skeletal muscle fibers with ahnak-C2 attenuated the decline in isometric force development upon repeated contraction−relaxation cycles. Our results suggest that the carboxyl-terminal ahnak domain exerts a stabilizing effect on muscle contractility via its interaction with actin of thin filaments.
sarcolemma, including T-tubular structures and the intercalated discs (10) . Recently, we identified the carboxyl-terminal 382 amino acid residues of ahnak (designated as ahnak-C2) as the interaction domain for the regulatory β subunit of L-type Ca 2+ channels and for F-actin (10) . Hence, we suggested that the carboxyl-terminal ahnak domain links the Ca 2+ channels to the actin-based cytoskeleton.
The actin cytoskeleton is a highly dynamic network of microfilaments composed of actin polymers and a large number of associated support proteins, which together define cell size and shape, both during development and once the cells have attained their terminally differentiated state. Furthermore, in differentiated myocytes, actin is the main component of the thin filament of the sarcomere. The minus end of the polarized actin filament directs to the center of the sarcomere, while the plus end is anchored into the Z-band or intercalated disc (12−14) . Thus, actin transmits force both between adjacent sarcomeres, as well as neighboring myocytes for coordinated contractions of myofibrils and the whole heart.
Here, we present evidence for the existence of an endogenous carboxyl-terminal ahnak fragment associated with myofibrils of cardiac, but not of skeletal muscle. Hence, demembranated skeletal muscle fibers were chosen as a model system to study the function of the recombinant carboxyterminal ahnak domain, ahnak-C2. We found that ahnak-C2 bound to demembranated skeletal muscle fibers and stabilized their contractile properties. Moreover, ahnak-C2 induced strong bundling of actin filaments, suggesting that the carboxyl-terminal ahnak region serves a stabilizing function along the sarcomere.
MATERIAL AND METHODS

Materials
The carboxy-terminal ahnak portion encompassing 382 amino acid residues (ahnak-C2) was expressed as GST-ahnak-C2 fusion protein in Escherichia coli BL21-CodonPlus-(DE3)-RIL (Stratagene) and purified from bacterial lysates as described previously (10) . The plasmid DNA was kindly provided by Dr. Emma Shtivelman (University of California, San Francisco, USA). The ahnak antibodies, KIS-Ab and ahnak-C2-Ab, used in this study have been characterized previously (5 and 10, respectively). Synthetic peptides for antibody generation were purchased from Biosyntan GmbH (Berlin-Buch, Germany). Sprague Dawley rats were obtained from a local source.
Antibody generation and purification
To generate an antibody reacting with the most carboxyl-terminal ahnak portion, the peptide KKSRLSSSSSNDSG corresponding to amino acid residues 5611-5624 of human ahnak (Fig.  1A ) was used for immunization of rabbits. The antibody-containing serum fractions were affinity purified on the peptide antigen column. The antibody was designated as Tail antibody (Tail-Ab). Purified Tail-Ab IgG (0.5 mg) prepared in amino group-free buffers were covalently coupled to BrCN-activated Sepharose 4B (Amersham-Pharmacia-Biotech Inc., Piscataway, NJ) according to the manufacturer's protocol to yield Tail-Ab affinity beads. The affinity-purified ahnak-C2 antibody was purified by a second round of affinity chromatography on the tail peptide antigen column to yield the C2/Tail-Ab.
Muscle preparations and Western blots
The total protein fractions were prepared as follows: Frozen tissue samples of heart and skeletal muscle (20−30 mg) were homogenized in SDS-sample buffer (5% SDS, 50 mM Tris/HCl-buffer, pH 7.4, 250 mM sucrose, 75 mM urea, 10 mM dithiothreitol), boiled for 2 min and centrifuged. The protein content of the supernatant was determined by a modified Lowry method (15) . For affinity bead assays, the rat cardiac total protein fraction (1 mg protein) was diluted to a final SDS concentration of 0.1% with CHAPS buffer consisting of 25 mM Tris-HCl (pH 7.4), 0.1% CHAPS, 50 mM NaCl, 0.1mM PMSF, 1 µM pepstatin A, 0.1 mM benzamidine, 1 mM iodoacetamide and were incubated with Tail-Ab affinity beads (100 µl swollen gel) for 15 h at 4°C on a rotating wheel. After binding, the beads were washed 5 times with CHAPS-buffer, resuspended in 2x SDS sample buffer, and the proteins released from the beads were subjected to SDS-PAGE and Western blotting. Cardiac myofibrils were prepared according to Solaro (16) . Briefly, cardiac tissue was repeatedly homogenized with standard buffer, consisting of 60 mM KCl, 30 mM imidazole, pH 7.0, and 2 mM MgCl 2 . These preparations were further purified by repeated treatment with 1% Triton-X100 in standard buffer. Purified myofibrils were suspended in standard buffer and stored at −20°C in the presence of 50% glycerol. For the detection of high molecular mass proteins, samples were separated on 6.5% SDS-polyacrylamide gels and transferred to nitrocellulose for 2 h at 300 mA. For the detection of low molecular mass proteins, samples were separated on 8% SDS-polyacrylamide gels and transferred for 90 min at 210 mA. The transfers were incubated with the affinity-purified ahnak antibodies at concentrations between 0.5 and 1 µg IgG/ml for 90 min at room temperature followed by the peroxidasecoupled anti-rabbit IgG (dilution 1:6.000, BioGenes, Berlin, Germany). Immunoreactive protein bands were visualized by the enhanced chemiluminescence (ECL) reaction (Amersham).
Immunocytochemistry on rat heart and skeletal muscle
Rat tissue from cardiac and skeletal muscle was prepared as described previously (5) . Briefly, tissue pieces were infiltrated with 2.3 M sucrose and rapidly frozen in liquid nitrogen. Sections of 1 µm thickness were prepared and collected on silane-coated glass slides. Immunolabeling was performed with the Tail-Ab diluted in blocking buffer to a concentration of 5 µg/ml for 2 h at 37°C. The primary antibody was visualized by incubation with a Cy3-labeled donkey antirabbit-IgG antibody (Dianova, 1:10.000) for 1 h at 37°C. Sections were evaluated with an Axioplan fluorescence microscope (Zeiss, Oberkochen, Germany) equipped with appropriate filter systems. Micrographs were taken with an automatic camera (Zeiss, Germany) on Fujichrome Provia 400 film.
Immunocytochemistry on human myocardium
Left ventricular myocardium from a human donor heart not used for transplantation was frozen in liquid nitrogen and stored in −80°C until use. Sections of 5 µm thickness were cut using a cryostat (Leica CM3000) and fixed in 4% formalin for 10 min. Sections were blocked with 0.1% BSA for 15 min and subsequently incubated with the Tail-Ab (3.5 µg IgG/ml) at room temperature for 3 h. For the detection system, a biotinylated donkey anti-rabbit IgG (Dianova) at a dilution of 1:100 was applied for 1.5 h followed by Cy2-conjugated streptavidin (Rockland) at a dilution of 1:100 for 1 h. For double-labeling experiments, α-actinin (clone EA-53, Sigma, 1:200) or myomesin (clone B4, kindly provided by Dr. Eppenberger, Zürich, Switzerland, 1:5) were stained overnight followed by an incubation step with rhodamine-conjugated goat antimouse IgG (Jackson ImmunoResearch Laboratories, West Grove, PA; 1:50, 2 h). Between all staining steps, slides were rinsed in phosphate-buffered saline, pH 7.4 3 times for 3 min. Omission of primary antibodies served as negative controls. Tissue sections were mounted with Mowiol (Hoechst), protected with cover glasses, and investigated using laser scanning confocal microscopy (Leica TCS SP). Series of confocal sections (0.5 µm interval) were taken through the specimen for consecutive three-dimensional reconstruction at a Silicon Graphics Octane workstation using multichannel image processing software Imaris and Selima (Bitplane).
Mechanical analysis
The mechanical experiments were performed with glycerinated, demembranated skeletal muscle fibers (skinned fibers) from M. gastrocnemius of 3-month-old rats. Skinning procedure was performed according to (17) . Briefly, small muscle bundles (1 mm thick) were tied on a wooden stick and skinned by incubation in 0.12 M K + acetate, 5 mM MgCl 2 , 5 mM EGTA, 20 mM TES, 50% glycerol, pH 7.0 at 4°C for 12 h. Subsequently, the tissue was stored in the same solution at −20°C. Muscles were dissected into fiber bundles of 100−150 µm diameter and 4−5 mm length. Fiber bundles were mounted horizontally between two microclamps in relaxation solution (20 mM imidazole, 10 mM ATP, 10 mM creatinphosphate, 380 U/ml creatine kinase, 5 mM NaN 3 , 5 mM EGTA, 12.5 mM MgCl 2 , 1 mM DTT, pH 7.0). One of the clamps was connected with a force transducer, the other one with a micrometer screw (Scientific Instruments, Heidelberg, Germany). Length was adjusted by the micrometer screw such that the resting tension was the threshold. Sarcomere length at resting tension was always between 2.0 and 2.25 µm, as detected by laser diffraction. The fibers were then transferred into contraction solution. Contraction solution contained the same constituents as relaxation solution except that EGTA was substituted by 4 mM Ca 2+ EGTA. Skinned fibers were activated at submaximal (pCa 5.8) and maximal (pCa 5.0) Ca 2+ activation and subsequently transferred into relaxing solution. Following muscle relaxation, 1 µM recombinant GST-ahnak-C2 or 1 µM GST-tag were added to the relaxing solution and the fibers were incubated for 30 min. Subsequently, the fibers underwent the second contraction−relaxation cycle under the conditions described for the first cycle, except that the solutions were complemented with either 1 µM recombinant ahnak-C2 or 1 µM GST. For immunoblot analysis of bound ahnak-C2 or GST (shown in Fig. 6 ), the fibers underwent two cycles and were extensively washed with relaxing solutions before the solubilization with SDS sample buffer was performed.
Electron microscopy
Actin was prepared from rabbit muscle acetone powder as described (18) . G-actin was polymerized in buffer A containing 0.1M KCl, 2 mM MgCl 2 , 1 mM DTT, 1 mM EGTA, 0.005% NaN 3 , 10 mM imidazol-HCl (pH 7.0). Recombinant GST-ahnak-C2 or unfused GST was added to preformed actin filaments (0.1 mg/ml) in molar ratios of actin: ahnak-C2 of 1:0.3 to 1:1 and dialyzed against buffer A overnight at 4°C. Samples were negatively stained with 1% uranyl formate using a double-carbon film technique (19) . Specimens were examined with an EM 910 (LEO, Germany) electron microscope at an accelerating voltage of 80 kV. Electron micrographs were taken at a magnification of 10.000.
Statistical analysis
The statistical analyses were performed using commercially available statistical programs (PRISM ® ) on an IBM ® compatible PC. Values are expressed as means ±SEM; n = number of fibers investigated. Significance analysis was performed using the Student's t test for unpaired values.
RESULTS
Expression and localization of ahnak in rat heart and skeletal muscle As a prerequisite for functional studies on muscle fibers, we analyzed ahnak expression in rat cardiac and skeletal muscle preparations. For this purpose, the established ahnak antibody (KISAb [5] ) was used in combination with a newly developed antibody, designated as Tail-Ab. This antibody was directed against a serine-rich epitope located nearly at the C terminus of the molecule (Fig. 1A) . The KIS-Ab reacted strongly with a high molecular mass protein of the expected size of ≈700 kDa and faintly with a ≈500 kDa protein on Western blots of total proteins from rat heart and rat skeletal muscle (Fig. 1B) . No additional proteins were stained by the KISAb in the range of low molecular mass proteins (Fig. 1C) . In contrast, size heterogeneity of ahnak was detected by the Tail-Ab. It reacted with the 700 kDa band rather faintly and additional bands migrating at ≈500 kDa, 340 kDa, and 170 kDa could be recognized in both muscle types (Fig. 1B) . A remarkable difference between the cardiac and skeletal muscle preparations was observed on blots of low molecular mass proteins. The Tail-Ab reacted very strongly with a protein of ≈40 kDa molecular mass in rat heart, whereas no comparable reaction was obtained in skeletal muscle (Fig. 1C) . Biochemical analysis revealed that this 40 kDa immunoreactive protein copurified with cardiac myofibrils, and it persisted in rat cardiac muscle fibers following demembranation (data not shown).
To get further insights in ahnak's subcellular distribution, immunolocalization studies were performed on sections of rat heart and skeletal muscle using the ahnak antibodies KIS-Ab and Tail-Ab. Immunocytochemistry of rat heart revealed Τail-Ab labeling as regularly spaced intracellular striations in longitudinal sections of cardiomyocytes ( Fig. 2A) . This labeling pattern was clearly different from that of the KIS-Ab which showed plasma membrane labeling in sections of the same tissue block (Fig. 2B) . In rat skeletal muscle, both the Tail-Ab (Fig. 2C ) and the KIS-Ab (Fig. 2D) showed clear plasma membrane labeling and no intracellular staining under the same experimental conditions. Taken together, these data suggest that the Tail-Ab reacts preferentially with a carboxyl-terminal ahnak fragment present in cardiac, but not in skeletal muscle myofibrils.
To test this hypothesis we employed the ahnak-C2 antibody raised against a carboxyl-terminal ahnak fragment of 382 amino acids (Fig. 1A) . On Western blots of total rat heart proteins, the ahnak-C2 antibody failed to react with low molecular mass proteins (data not shown). However, the ahnak-C2 Ab reacted specifically with a ≈70 kDa protein following immunoprecipitation of rat cardiac proteins with Tail-Ab beads (Fig. 1D ).
Expression and localization of ahnak in human myocardium
Because the antibodies used in this study were raised against deduced human ahnak peptides and fragments, we used human cardiac preparations for further expression studies. Figure 3 demonstrates the immunorecognition pattern of different carboxyl-terminal ahnak antibodies on human cardiac total proteins and human myofibrillar protein preparations. The 700 kDa ahnak was strongly detected by the ahnak-C2-Ab and weakly detected by the Tail-Ab in the total protein fraction (Fig. 3A, lanes 1, 3) . It was absent from the myofibrillar fraction (Fig. 3A, lanes  2, 4) and no additional immunoreactive bands were obtained on Western blots of human heart high molecular mass proteins (Fig. 3A) . In the range of low molecular mass proteins (Fig. 3B) a protein of 72 ± 3 kDa (n=5) was identified by both the C2/Tail-Ab (lanes 3, 4) and the Tail-Ab (lanes 5, 6) . The C2-Ab without epitope separation by a second round of affinity chromatography did not recognize any low molecular mass protein (Fig. 3B, lanes 1, 2) . The Tail-Ab staining at 72 kDa is considered to be ahnak-specific since it is entirely blocked by the inclusion of the GST fusion protein ahnak-C2, but not GST alone (Fig. 3B, lanes 7, 8 vs. 5, 6 ). This 72 kDa putative carboxyl-terminal ahnak fragment clearly copurified with cardiac myofibrils (Fig. 3, lanes 4, 6) .
Its subcellular distribution was further studied by immunohistochemistry using the Tail-Ab in combination with labeling of α-actinin and myomesin. Confocal imaging of longitudinal sections of normal human myocardium revealed labeling of ahnak's Tail-Ab epitope in regular cross striations (Fig. 4A) . A very similar picture was obtained for α-actinin in its typical regular crossstriated pattern at the level of the Z-line (Fig. 4B ) indicating partial colocalization of ahnak's tail epitope and α-actinin (Fig. 4C) . In addition, the intercalated disc was stained by the Tail-Ab (Fig. 4A, arrow) . The images at the lower panel of Fig. 4 compare the location of ahnak's TailAb epitope and the M-band protein, myomesin. Again, the regular cross-striated pattern was clearly obtained with the Tail-Ab (Fig. 4D ) and as expected for myomesin at the M-band of the sarcomere (Fig. 4E) . Notably, merged images of both proteins revealed a clear alternate staining pattern for ahnak's tail epitope and myomesin (Fig. 4F) .
Skeletal muscle fibers are stabilized by ahnak-C2
Since results from immunoblotting and immunofluorescence on skeletal muscle demonstrated the absence of an endogenous carboxyl-terminal ahnak fragment, we used skeletal muscle fibers to elucidate the functional role of exogenously added ahnak-C2 (Fig. 1A) . Isometric force development of demembranated skeletal muscle fibers (M. gastrocnemius) was monitored at submaximal (pCa 5.8) and at maximal (pCa 5.0) Ca 2+ activation. Figure 5A shows a representative registration of isometric force development under control conditions during two subsequent contraction-relaxation cycles. When isometric force development of the first contraction cycle was compared with that of the second contraction cycle, we observed a significant decrease in force development at both submaximal and maximal Ca 2+ activation (Fig.  5A) . Pooled data reveal that in the second contraction−relaxation cycle force dropped to 23.3 ± 5.9% (pCa 5.8) and 71.4 ± 3.1% (pCa 5.0) of the force obtained at the first contraction−relaxation cycle (Table 1 ). This decline of isometric force development during the second contraction−relaxation-cycle was even more pronounced upon incubation of the fibers with the GST-tag (Fig. 5C, Table 1 ). In contrast, addition of GST-ahnak-C2 to the fibers attenuated this decline of force during the second contraction−relaxation cycle significantly: Isometric force development at submaximal Ca 2+ activation (pCa 5.8) declined to 43.8 ± 4.8% in the presence of 1 µM GST-ahnak-C2 and force development at maximal Ca 2+ activation (pCa 5.0) could be maintained at the level of the first contraction−relaxation cycle (Fig. 5B, Table 1 ).
Subsequently, we analyzed whether recombinant ahnak-C2 is bound to muscle fibers during this protocol. Immmunoblot analysis using the Tail-Ab revealed that skinned skeletal muscle fibers showed no immunoreaction before incubation, whereas they contained ahnak-C2 following incubation with 1 µM ahnak-C2 and subsequent contraction−relaxation cycle and washing procedures (Fig. 6, lanes 2, 3) . Unfused GST which served as a control was not retained in the fiber preparation under identical experimental conditions as assessed by a GST-specific antibody (Fig. 6, lanes 5, 6) . The antibodies were adjusted to detect similar amounts of recombinant ahnak-C2 and GST (Fig. 6, lanes 1, 4) . Notably, the Tail-Ab reacted strongly with recombinant ahnak-C2.
Ahnak-C2 has actin-bundling activity
Since ahnak-C2 was shown to bind actin (10), it is reasonable to study whether the stabilizing effect of ahnak-C2 on muscle contractility is connected to an effect on thin filament organization. For structural studies actin filaments polymerized from purified skeletal muscle Gactin were incubated with GST-ahnak-C2 and inspected by electron microscopy. GST-ahnak-C2 added to actin filaments induced different stages of actin filament bundling ranging from loose bundles to tight packing into paracrystalline-like structures (Fig. 7A) . The formation of paracrystalline-like structures was already observed at a molar ratio of 1:0.3 (actin: GST-ahnak-C2). The proportion of these structures increased at molar ratios of 1:0.5 and 1:1. The thickness of bundles was up to 250 nm (Fig. 7A) . To exclude possible influence of the GST sequence on bundling activity, actin filaments were incubated with unfused GST in the same molar ratios as for GST-ahnak-C2. No actin bundling was observed with unfused GST (Fig. 7B) . Thus, electron microscopy data clearly demonstrate the carboxyl-terminal ahnak domain to possess actinbundling activity.
DISCUSSION
In this report, we present evidence for a cardiac-specific processing of ahnak releasing a small carboxyl-terminal fragment from the giant protein. This fragment distributes to the myofibrillar Z-line and to the intercalated discs of cardiomyocytes.
The observation of cardiac-specific ahnak processing based on the comparison of Western blot results from cardiac and skeletal muscle myocytes. The peptide antibody, designated as Tail-Ab, directed against the most carboxyl-terminal region of the 700 kDa ahnak protein revealed size heterogeneity of ahnak. In both muscle types, discrete ahnak forms were detected ranging from 700 kDa to 170 kDa. Importantly, one smaller Tail-Ab-positive protein exhibiting strong immunoreaction (40 kDa and 72 kDa in rat and human heart, respectively) was observed in cardiac myocytes but not in skeletal muscle. Although the immunorecognition pattern of the Tail-Ab was not identical to that of the KIS-Ab and the ahnak-C2-Ab, evidence for specific recognition of ahnak's C terminus was provided by the findings that 1) the Tail-Ab detected recombinant ahnak-C2 with high sensitivity, 2) the immunoreaction of the Tail-Ab was clearly blocked by inclusion of the immunogenic peptide and the recombinant ahnak-C2 fragment, and 3) the Tail-Ab recognized also full-length ahnak. Therefore, we propose that post-translational processing of ahnak produces tissue-and species-specific ahnak fragments and that the Tail-Ab is a useful tool to recognize these fragments. Immunocytochemistry with the Tail-Ab supports the existence of a cardiac-specific, carboxyl-terminal ahnak fragment and adds information about its localization. Labeling of myofibrillar structures was obtained in rat cardiac sections, whereas skeletal muscle sections were clearly devoid of intracellular labeling. Importantly, the Tail-Ab labeled the plasma membrane of skeletal muscle myocytes confirming the expected recognition of the full-length ahnak antigen in a tissue devoid of the carboxyl-terminal ahnak fragment. Myofibrillar distribution of the cardiac-specific ahnak fragment was further corroborated by biochemical copurification. One limitation of our study is that the ahnak-C2 antibody should also react with carboxyl-terminal ahnak fragments. Possible explanations for the failure of this antibody include abnormal epitope presentation and the formation of SDS-stable complexes containing ahnak's Tail-Ab epitope in either hetero-or homo-oligomers. The latter assumption is supported by the result that the ahnak-C2 antibody reacts strongly with the myofibrillar ahnak fragment after epitope-splitting using the tail peptide. Nevertheless, we cannot say at this time whether the Tail-Ab-positive protein is identical to a carboxyl-terminal ahnak fragment of definite size, since we were not able to analyze the amino acid sequence. The amount of protein was too small for sequencing. Thus, further upscaled experiments using higher amounts need to be done for final identification.
To date, more than 60 different proteins directly interacting with actin have been identified (21) . Results from electron microscopy presented here add ahnak and the carboxyl-terminal ahnak fragment to the family of actin-bundling proteins. Ahnak-C2-induced actin filament bundling into paracrystalline-like structures. Actin bundling in such a highly ordered manner is comparable to the activity of other actin binding proteins like α-actinin (22), fimbrin (23) , or the growth arrest-specific protein Gas7 (24) . In general, a prerequisite for the bundling activity of actin-binding proteins is the presence of two independent actin binding sites, either on the single protein subunit or as a result of dimerization or oligomerization processes. Secondary structure predictions failed to identify two potential regions capable of forming actin-binding sites in the ahnak-C2 region. Although our previous results from analytical ultracentrifugation revealed that ahnak-C2 is monodispers in solution up to 0.8 µM (10), we cannot rule out a dimerization of ahnak-C2 in actin bundling experiments presented herein, which were performed at higher concentrations of ahnak-C2 (2.4 µM). Knowledge of the exact binding motifs will allow predictions about the mode of interaction defining the distance between and the relative orientation of the two actin binding domains.
Confocal microscopy of human left ventricular tissue with the Tail-Ab localized the carboxylterminal ahnak fragment to the Z-line of myofibrils and to the intercalated disc. Thus, in cardiomyocytes, full-length ahnak and the carboxyl-terminal ahnak fragments appear to differ in their subcellular distribution. Antibodies reacting with the 700 kDa full-length ahnak collectively reveal sarcolemmal location (5, 10, 11), while the Tail-Ab preferentially reacting with the carboxyl-terminal fragment reveals myofibrillar (Z-line) location. These observations suggest that ahnak interacts with actin at specific sites: Full-length ahnak anchors sarcolemma proteins (e.g., L-type Ca 2+ channels) to the subsarcolemma actin-based cytoskeleton (10), while the carboxyl-terminal ahnak fragment accumulates at the level of Z-lines and intercalated discs for interaction with myofibrillar F-actin. Both myofibrillar Z-line structures and intercalated discs play a crucial role in the establishment and maintenance of cardiomyocyte cytoarchitecture and contractile function.
To gain insights into a potential functional role of ahnak−actin interaction within the contractile apparatus, we investigated a model that is devoid of both sarcolemma-associated and myofibrillar endogenous ahnak, but retains the contractile properties of myofibrils. Demembranated (skinned) muscle fiber preparations from skeletal muscle fulfill these requirements. Isometric force development of chemically skinned skeletal muscle fibers declined when subjected to repeated contraction-relaxation cycles. In contrast, skinned cardiac muscle fibers are relatively stable in vitro in that repeated contraction−relaxation cycles are possible without substantial decline in force development at maximal Ca 2+ activation (25) . In this study, we demonstrate a stabilization of the contractile properties of skinned skeletal muscle fibers by ahnak-C2.
Ahnak is encoded by an intronless gene, suggesting that the smaller proteins identified by ahnak antibodies are probably proteolytic fragments of ahnak rather than splice variants. Considering ahnak's involvement in fundamentally different functions such as cell differentiation (1, 2), signal transduction (3−6), and plasma membrane support (10, 11) , it seems reasonable to suggest the existence of post-translationally processed ahnak isoforms, which serve different cell-typespecific functions. In fact, endogenous proteolytically derived fragments comprised of ahnak's repeating units have been isolated from bovine lung (4). The fragments bind and activate phospholipase C-γ in the presence of arachidonic acid (4).
Taken together, we have demonstrated that the most carboxyl-terminal ahnak domain of 382 amino acids has actin-bundling capacity and stabilizes the contractile apparatus of muscle fibers. Its subcellular distribution at the Z line and intercalated disc suggests an integrative role in transmission of mechanical strain along the sarcomere and the whole heart.
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